Effect of a mobile health, sensor-driven asthma management platform on asthma control

Barrett, Meredith A.; Humblet, Olivier; Marcus, Justine E.; Henderson, Kelly; Smith, Theodore; Eid, Nemr; Sublett, J. Wesley; Renda, Andrew; Nesbitt, LaQuandra; Sickle, David Van; Stempel, David A.; Sublett, James

doi:10.1016/j.anai.2017.08.002

Cited by 61 publications

(36 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Very few apps had been clinically validated and many were not based on guidelines or clinical evidence. Since then, various studies have evaluated the advantages, usability, efficiency, and risks of mobile health technologies in allergic rhinitis, asthma, atopic dermatitis, food allergy, and anaphylaxis …”

Section: Becoming Wireless—the Frantic Evolution Of Information and Cmentioning

confidence: 99%

The role of mobile health technologies in allergy care: An EAACI position paper

Matricardi

Dramburg

Alvarez-Perea

et al. 2019

Allergy

109

111

View full text Add to dashboard Cite

Mobile health (mHealth) uses mobile communication devices such as smartphones and tablet computers to support and improve health‐related services, data and information flow, patient self‐management, surveillance, and disease management from the moment of first diagnosis to an optimized treatment. The European Academy of Allergy and Clinical Immunology created a task force to assess the state of the art and future potential of mHealth in allergology. The task force endorsed the “Be He@lthy, Be Mobile” WHO initiative and debated the quality, usability, efficiency, advantages, limitations, and risks of mobile solutions for allergic diseases. The results are summarized in this position paper, analyzing also the regulatory background with regard to the “General Data Protection Regulation” and Medical Directives of the European Community. The task force assessed the design, user engagement, content, potential of inducing behavioral change, credibility/accountability, and privacy policies of mHealth products. The perspectives of healthcare professionals and allergic patients are discussed, underlining the need of thorough investigation for an effective design of mHealth technologies as auxiliary tools to improve quality of care. Within the context of precision medicine, these could facilitate the change in perspective from clinician‐ to patient‐centered care. The current and future potential of mHealth is then examined for specific areas of allergology, including allergic rhinitis, aerobiology, allergen immunotherapy, asthma, dermatological diseases, food allergies, anaphylaxis, insect venom, and drug allergy. The impact of mobile technologies and associated big data sets are outlined. Facts and recommendations for future mHealth initiatives within EAACI are listed.

show abstract

Section: Becoming Wireless—the Frantic Evolution Of Information and Cmentioning

confidence: 99%

The role of mobile health technologies in allergy care: An EAACI position paper

Matricardi

Dramburg

Alvarez-Perea

et al. 2019

Allergy

109

111

View full text Add to dashboard Cite

show abstract

“…The development of simple reminder systems or alarms includes the use of sensors on medication bottles or inhalers [30]. Sensors can be programmed to turn certain colors or emit a reminder sound when the bottle has not been opened or the inhaler has not been used at a prespecified time.…”

Section: Adherence Systemsmentioning

confidence: 99%

Impact Of “eHealth” in Allergic Diseases and Allergic Patients

Alvarez-Perea¹,

Sánchez-García²,

R³

et al. 2019

J Investig Allergol Clin Immunol

View full text Add to dashboard Cite

The emergence of new technology enables allergists and patients to compile data and receive feedback regarding key symptoms, risk behavior, and/or management. The term "eHealth" refers to a diverse group of tools that use computerized technologies to improve both the efficacy and the efficiency of the health care industry. eHealth comprises a variety of technologies, as follows: mobile devices (mHealth) in medical care, including electronic diaries, wearable sensors, and adherence monitoring; health informatics (eg, electronic health records, computerized physician order entry, clinical decision support); telemedicine, which is the use of information and communication technologies for the management of diseases and medical education; social media platforms, and the analysis of information acquired through these platforms using "big data" technologies. In this review, we summarize the latest findings on the use of eHealth technology and the relevance of eHealth to allergic conditions. ResumenLa aparición de nuevas tecnologías conlleva para los alergólogos y los pacientes la posibilidad de recopilar datos y recibir información directa sobre los síntomas clave de las enfermedades, los comportamientos de riesgo y/o su manejo. El término "eHealth", o salud electrónica, se refiere a un grupo diverso de herramientas que utilizan tecnologías informáticas para mejorar la eficacia y la eficiencia de la industria de la salud. La "eHealth" comprende varias tecnologías, como el uso de dispositivos móviles aplicados a la salud ("mHealth"), incluyendo diarios electrónicos, sensores ponibles o monitorización de la adherencia terapéutica; la informática biomédica (por ejemplo, la historia clínica electrónica, la prescripción electrónica o los sistemas de ayuda a las decisiones clínicas); la telemedicina, que es el uso de las tecnologías de la información y la comunicación para el manejo de enfermedades y de educación sanitaria; las plataformas de redes sociales, y el análisis de la información adquirida a través de estas plataformas, usando técnicas de "big data" o inteligencia de datos. En esta revisión, resumimos la evidencia que rodea al uso de tecnologías "eHealth" y su relevancia para las enfermedades alérgicas.

show abstract

“…The use of digital health technologies to support self-management and clinical care for asthma is becoming increasingly common and has demonstrated positive clinical outcomes (38)(39)(40)(41)(42). Previous digital health studies have leveraged the inhaler use data collected by sensors in clinical applications and in environmental health studies (4), but these studies have only focused on a single region and were limited by smaller sample sizes.…”

Section: Background and Datamentioning

confidence: 99%

Short-term impact of PM _2.5 on contemporaneous asthma medication use: Behavior and the value of pollution reductions

Williams

Phaneuf

Barrett³

et al. 2018

Proc. Natl. Acad. Sci. U.S.A.

Self Cite

View full text Add to dashboard Cite

Asthma ranks among the most costly of chronic diseases, accounting for over $50 billion annually in direct medical expenditures in the United States. At the same time, evidence has accumulated that fine particulate matter pollution can exacerbate asthma symptoms and generate substantial economic costs. To measure these costs, we use a unique nationwide panel dataset tracking asthmatic individuals’ use of rescue medication and their exposure to PM2.5(particulate matter with an aerodynamic diameter of <2.5 μm) concentration between 2012 and 2017, to estimate the causal relationship between pollution and inhaler use. Our sample consists of individuals using an asthma digital health platform, which relies on a wireless sensor to track the place and time of inhaler use events, as well as regular nonevent location and time indicators. These data provide an accurate measurement of inhaler use and allow spatially and temporally resolute assignment of pollution exposure. Using a high-frequency research design and individual fixed effects, we find that a 1 μg/m3(12%) increase in weekly exposure to PM2.5increases weekly inhaler use by 0.82%. We also show that there is seasonal, regional, and income-based heterogeneity in this response. Using our response prediction, and an estimate from the literature on the willingness to pay to avoid asthma symptoms, we show that a nationwide 1 μg/m3reduction in particulate matter concentration would generate nearly $350 million annually in economic benefits.

show abstract

Effect of a mobile health, sensor-driven asthma management platform on asthma control

Cited by 61 publications

References 24 publications

The role of mobile health technologies in allergy care: An EAACI position paper

The role of mobile health technologies in allergy care: An EAACI position paper

Impact Of “eHealth” in Allergic Diseases and Allergic Patients

Short-term impact of PM _2.5 on contemporaneous asthma medication use: Behavior and the value of pollution reductions

Contact Info

Product

Resources

About

Effect of a mobile health, sensor-driven asthma management platform on asthma control

Cited by 61 publications

References 24 publications

The role of mobile health technologies in allergy care: An EAACI position paper

The role of mobile health technologies in allergy care: An EAACI position paper

Impact Of “eHealth” in Allergic Diseases and Allergic Patients

Short-term impact of PM 2.5 on contemporaneous asthma medication use: Behavior and the value of pollution reductions

Contact Info

Product

Resources

About

Short-term impact of PM _2.5 on contemporaneous asthma medication use: Behavior and the value of pollution reductions